Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: FOR, POL

Broad Coalition Of Leaders And Organizations Call For Global Summit To End The COVID-19 Pandemic


WASHINGTON, Sept. 1, 2021 /PRNewswire/ -- A coalition of 80 global leaders and over 25 organizations across corporate, philanthropic, civil society, advocacy, academic, and health sectors today called on world leaders attending the United Nations General Assembly this month to convene a global summit to ignite an urgent global action plan to end the pandemic.

In a statement being sent to President Joe Biden, United Nations Secretary General António Guterres, and G20 leaders, the coalition called on world leaders to convene a global summit during this year's United Nations General Assembly and commit to actions to make 7 billion doses of high-quality vaccines available before the end of 2021, and an additional 7 billion doses by mid-2022; ensure that every country is ready to implement equitable vaccination programs at scale by the end of this year; and to vaccinate 70 percent of the world's population by mid-2022. People everywhere should also have equitable access to tests, therapies, and other proven interventions so lives can be saved using all COVID-19 tools.

The coalition includes former senior government officials, former heads of major multilateral organizations, public health experts, heads of major foundations, and other leaders in the United States, United Kingdom, Europe, and Africa.

"We need a comprehensive response to the current crisis, which will also strengthen health systems and preparedness for the next pandemic. We are in a race against time. Without immediate action, there will be millions more infections and deaths, and new variants could emerge and pierce vaccine immunity," the statement said.

The full statement and list of signers of the statement can be found at:
https://www.covidcollaborative.us/global-covid-19-summit#letter-global-summit

Note to editors:

The call to action was coordinated by the COVID Collaborative, Duke-Margolis Center for Health Policy, Duke Global Health Innovation Center, Duke Global Health Institute, and the Pandemic Action Network. For more information on their work visit:

www.covidcollaborative.us 
www.healthpolicy.duke.edu 
http://dukeghic.org 
www.globalhealth.duke.edu 
www.pandemicactionnetwork.org

Contact:
Krishna Udayakumar
Director, Duke Global Health Innovation Center
Duke University
[email protected] 
+1-919-699-6024


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: